AI&I news

  • Prof. Joppe Hovius Appointed Head of Infectious Diseases at Amsterdam UMC
    Prof. Joppe Hovius Appointed Head of Infectious Diseases at Amsterdam UMC As of 1 November 2026, Prof. Hovius will take on a new challenge as Head of the Section of Infectious Diseases at Amsterdam UMC.
  • VACCINATION IMPACT | Advancing Hepatitis C Vaccine Research at AI&I
    VACCINATION IMPACT | Advancing Hepatitis C Vaccine Research at AI&I At the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), vaccination is one of three key research pillars, alongside PAIS and Immunomonitoring. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our focus is on Vaccination. In collaboration with AI&I researcher Dr. Kwinten Sliepen, we share the story of how vaccination research at AI&I is making a difference.
  • VACCINATION RESEARCH | Challenges and Developments in Vaccination Research from Infectious Diseases to Cancer
    VACCINATION RESEARCH | Challenges and Developments in Vaccination Research from Infectious Diseases to Cancer At the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), we focus on three key research areas: Post-Acute Infection Syndromes (PAIS), Immunomonitoring, and Vaccination. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our spotlight is on Vaccination. In this article, written in collaboration with AI&I researcher Prof. Joke den Haan, we explore the challenges and developments in vaccination research.

Submit your newsitem

Subscribe to our Newsletter

 Subscribe to our  Newsletter

All news from Amsterdam institute for Immunology and Infectious Diseases

Submit your newsitem